Answers are grounded in this paper and cite their sources.
This research demonstrates a novel 3D-printed mould platform for ex vivo sampling of prostate cancer, potentially advancing cancer studies.
Our 3D-printed mould platform allows for ex vivo sampling of MRI identified and previously biopsied prostate cancer at the time of RARP. The native, cancerous tissue may then be used to advance further research. The potential applications for a platform that can reliably sample living prostate cancer tissue are numerous, including the ability to advance future cancer research as well as other solid-organ malignancies with targetable lesions.
No takes yet. Share an insight, caveat, or question.
Du et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: